![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, April 25, 2015 1:56:14 PM
Examples:
$DNDN
April 13th, 2009: On news of the Phase III clinical trial of it’s prostate cancer drug (Provenge) being successful, Dendreon Corp’s (a leader in cancer drug research) stock price sky-rocketed from $7.30 to $18.85.
This represents an increase of 158% in just one day
This would mean that if you had invested $100,000 in DNDN on April 12th, 2009, you would have had close to $258,000 the next day!
$VNDA
May 7th, 2009: Vanda Pharmaceuticals Inc. announces the FDA approval of its schizophrenia drug, Fanapta. This caused the company’s stock to multiple nearly 8 times from $1.08 to $8.80.
That is an increase of just over 714%!
Again, this would mean that if you had invested $100,000 in VNDA on May 6th, 2009, you would have had over $814,000 the next day!
Now I know the above doesn't happen for all stocks but we're in sub penny's where FDA approvals are like Bigfoot, talked about but never seen.
I watched $ADMD run to 0.0041 from 0.0031 within 4 minutes after the PR about restructuring. Can you imagine if it were FDA approval news? I can. Multiple pennies within an hour.This stock will reach $0.10. And when it does, we will break and see 0.25+.
Now is the time to decide whether you want to be the nail or the hammer.
Disclaimer: The statement above is my personal opinion and are not facts unless supported by legitimate documentation or material. Please do your own due diligence regarding this security. I have never been paid or compensated by anyone for any stock I've
Recent RDGL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:28:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM